NASDAQ: AHIAdvanced Health Intelligence Ltd Stock
$1.50+0.00 (+0%)
Updated Apr 12, 2024
AHI Price
$1.50
Fair Value Price
N/A
Market Cap
$11.76M
52 Week Low
$0.64
52 Week High
$15.52
P/E
-0.77x
P/B
5.8x
P/S
8.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.79M
Earnings
-$12.83M
Gross Margin
100%
Operating Margin
-451.68%
Profit Margin
-459.7%
Debt to Equity
3.39
Operating Cash Flow
-$7M
Beta
0.56
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AHI Overview
Advanced Human Imaging Limited offers measurement/dimensioning technology that enables end-users to check, track, and assess body dimensions privately using a smartphone. Its scanning offerings include BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves the telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. AHI was incorporated in 2014 and is based in South Perth, Australia.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AHI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AHI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AHI is good value based on its book value relative to its share price (5.8x), compared to the US Software - Application industry average (6.49x)
P/B vs Industry Valuation
AHI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AHI due diligence checks available for Premium users.
Be the first to know about important AHI news, forecast changes, insider trades & much more!
AHI News
Valuation
AHI fair value
Fair Value of AHI stock based on Discounted Cash Flow (DCF)
Price
$1.50
Fair Value
-$0.18
Undervalued by
929.72%
AHI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AHI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.77x
Industry
101.91x
Market
40.97x
AHI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.8x
Industry
6.49x
AHI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AHI's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
AHI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AHI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.9M
Liabilities
$6.9M
Debt to equity
3.39
AHI's short-term liabilities ($6.03M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AHI's short-term assets ($3.25M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AHI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
AHI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AHI vs App Stocks
Advanced Health Intelligence Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.